Recombinant Human RRAS2 Protein，GST

RRAS2, a member of the RAS superfamily of small GTPases, plays a crucial role in various cellular processes, including cell proliferation, differentiation, and survival. It is known to be involved in signaling pathways that regulate cytoskeletal dynamics and gene expression, making it significant in cancer biology and other diseases. The understanding of RRAS2's function has been muddied by the complexity of RAS-mediated signaling networks. Researchers have increasingly focused on characterizing RRAS2 as a potential therapeutic target, especially in cancers where its expression or activity is dysregulated. The production of recombinant RRAS2 protein through various expression systems enables in-depth studies of its biochemical properties, interaction partners, and functional implications in signaling pathways. By examining the protein's role in oncogenesis and other cellular contexts, scientists aim to elucidate its potential as a biomarker or therapeutic target. Current efforts include investigating RRAS2's structural characteristics and its interactions with small molecules, which could pave the way for novel treatment strategies in RRAS2-associated malignancies. Overall, the study of RRAS2 recombinant protein is not only pivotal for advancing basic research in cell signaling but also holds promise for translational applications in cancer therapy.